Epigenomics AG
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Epigenomics AG's past years’ income statements indicate that its last revenue has increased compared to the previous period by 637% to $6,203,000. The net income raised on -$2,428,000 and profit margin reached -39%. Total operating expenses were $10,229,000.

Profit Margin

Epigenomics AG (OTC:EPGNY): Profit margin
2012 1.03M -12.19M -1173.92%
2013 1.58M -7.41M -466.69%
2014 1.50M -8.85M -587.52%
2015 2.08M -8.98M -431.56%
2016 4.20M -11.16M -265.67%
2017 1.86M -10.23M -549.09%
2018 1.53M -12.69M -827.92%
2019 1.12M -17.02M -1512.89%
2020 842K -11.68M -1387.89%
2021 6.20M -2.42M -39.14%

EPGNY Income Statement (2012 – 2021)

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Revenue
Revenue
6.20M842K1.12M1.53M1.86M4.20M2.08M1.50M1.58M1.03M
Cost of revenue
136K145K253K440K246K1.63M1.17M731K487K292K
Gross profit
6.06M697K872K1.09M1.61M2.56M907K776K1.10M747K
Operating exp.
Research and development
3.11M3.65M7.34M6.41M4.32M5.11M5.76M4.68M4.37M8.01M
Selling and marketing
4.43M3.46M4.52M4.17M4.66M0004.50M0
Total operating expenses
10.22M10.81M15.97M14.38M11.47M15.00M10.18M9.11M8.30M12.85M
Operating income
-2.35M-11.62M-14.67M-12.89M-10.28M-12.31M-9.26M-8.38M-7.28M-12.12M
Other income (expenses), net
-52K-36K107K-535K-160K16K15K-498K11K80K
Income before tax
-2.41M-11.66M-14.56M-13.43M-10.44M-12.29M-9.24M-8.88M-7.27M-12.04M
Income tax expense
18K23K2.45M-738K-214K-1.13M-264K-27K134K154K
Net income
-2.42M-11.68M-17.02M-12.69M-10.23M-11.16M-8.98M-8.85M-7.41M-12.19M
Earnings per share
Basic EPS
-0.27-2.48-4.48-4.48-3.93-4.9-4.67-5.77-5.53-44.98
Diluted EPS
-0.27-2.48-4.48-4.48-3.93-4.9-4.67-5.77-5.53-44.98